Tribbles are members of the pseudokinase family of proteins, with no associated kinase activity detectable to date. As tribbles appear not to function as kinases, there has been debate surrounding their functional classification. Tribbles have been proposed to function as adaptor molecules facilitating degradation of their target proteins. Tribbles have also been proposed to mediate signalling changes to MAPK (mitogen-activated protein kinase) cascades and also to function as decoy kinases interfering with the activity of known kinases. The present review discusses the functionally divergent roles of tribbles as molecular adaptors mediating degradation, changes to signalling cascades and action as decoy kinases.
subdomain II and also a catalytic aspartate residue in the DLKLRKF sequence in subdomain VIB [5] . Tribbles proteins lack the GXGX 2 GXV motif in subdomain I which is necessary for anchoring ATP and they lack the highly conserved HRD (His-Arg-Asp) sequence in the catalytic cleft VIB necessary for phosphate transfer. Tribbles proteins also lack the DFG (Asp-Phe-Gly) triplet, the aspartate residue chelates Mg 2 + which is necessary for catalysis and ATP orientation in subdomain VII [5] .
Tribbles has the predicted three-dimensional structure of a kinase (SWISS-MODEL); however, to date, no kinase activity has been documented for the proteins [5, 8] . Lack of detectable kinase activity is either attributable to the kinase having unique untested substrates or that it is a true pseudokinase, a family of proteins which are predicted to comprise 10% of the human kinome [1, 4, 9] . A pseudokinase is defined as a protein which has a kinase-like domain, but lacks conserved motifs that are necessary for catalytic activity. These proteins are present on multiple branches of the human kinase tree, suggesting that they evolved independently of active kinases with distinct cellular roles [9] .
The C-terminal region contains two motifs: a COP1 (constitutive photomorphogenic Both the COP1-and MEK1-binding motifs are highly conserved in mammalian tribbles homologues [3, 10] . The presence of these two distinct protein-binding sites highlights the functionally diverse roles of tribbles.
In the absence of detectable kinase activity, tribbles have been reported to act as adaptor or scaffold proteins, either facilitating the assembly of multiprotein complexes which result in a phosphorylation change or in the degradation of their target proteins. A conundrum exists in defining tribbles functionality. Are they degradation-mediating proteins or are they signal mediators, or both? Tribbles proteins have also been classified as decoy kinases that do not exert kinase-like activity, but impede the function of other kinases through obstructive binding. The present review aims to summarize the diverse reports of tribbles functions in the context of mediating degradation, mediating changes to cell signalling and as a docking kinase.
Tribbles-mediated degradation
Tribbles catabolic interactions were first discovered in Drosophila where tribbles was identified as a mitotic inhibitor. Tribbles is necessary for controlling cell division, cell fate determination in cell morphogenesis and cell migration during gastrulation [4, 11] . Tribbles was identified in Drosophila to promote proteasome-mediated degradation of String, the homologue of mammalian CDC25, resulting in a stall in mitosis necessary for ventral furrow formation during gastrulation [4, 11, 12] . Loss-of-function mutations in tribbles phenotypically manifests as fruitflies with furry wings, hence the name tribbles, after the furry creatures in Star Trek [4, 11] . Tribbles has been demonstrated to mediate proteasomal degradation of Slbo (slow border cells), the homologue of mammalian C/EBP (CCAAT/enhancerbinding protein) [13] . Slbo is crucial for border cells migration during oogenesis [14] . This proteolytic relationship has been highly conserved in mammals with tribbles proteins retaining the ability to degrade members of C/EBP family of transcription factors. There are six members of C/EBP family [C/EBPα, C/EBPβ, C/EBPδ, C/EBPε, C/EBPζ (or CHOP for C/EBP-homologous protein) and C/EBPγ ]. These bZIP (basic leucine zipper) transcriptional factors are important mediators of cell proliferation, survival, differentiation and apoptosis in different tissues. Both mammalian TRIB1 and TRIB2 have been shown to degrade C/EBPα in AML (acute myeloid leukaemia) murine models, whereas only TRIB2 has been shown to degrade C/EBPα in lung cancer models. Additionally, TRIB2 has also been shown to degrade C/EBPβ in adipogenesis [3, [15] [16] [17] .
There is increasing evidence supporting the role of TRIB1 and TRIB2 as oncogenes and as genes displaying misregulated expression in leukaemia [3, [18] [19] [20] [21] [22] . Despite sequence similarity, TRIB3 appears to functionally separate from TRIB1 and TRIB2 as it does not have a recognized role in leukaemia to date. TRIB1 was identified to cooperate with HoxA9/Meis1, and TRIB2 was identified to co-operate with HoxA9, resulting in a reduced latency of AML in murine models [22, 23] . AML is characterized by a block in differentiation and increase in proliferation of immature blast cells, which infiltrate the bone marrow and enter the peripheral blood. TRIB1 and TRIB2 are both highly expressed in haemopoietic tissue [18] . TRIB2 was initially linked to leukaemia as a downstream target of the NOTCH1 pathway in a T-ALL (T-cell acute lymphoblastic leukaemia) cell line [15] . TRIB2 was identified to be a potent murine oncogene capable of inducing transplantable AML with complete penetrance [15] . The pathogenicity of TRIB2 was attributed to its ability to bind C/EBPα and mediate proteasomal degradation of C/EBPα [15] . Mutant studies showed that, in the absence of TRIB2-mediated C/EBPα degradation, leukaemia was not induced [24] . C/EBPα is a critical regulator of myeloid cell differentiation in haemopoietic development and is dysregulated by various mechanisms in approximately 50% of AML patients [25] . Further analysis of the critical leukaemogenic domains of TRIB2 revealed that deletion of the N-terminus had no effect on the ability of TRIB2 to induce AML or to degrade C/EBPα, indicating that the N-terminal region is not necessary for TRIB2's oncogenicity [24] . Interestingly, the N-terminus is the least conserved region of the protein [24] . Deletion of the N-and C-terminal flanking regions of the kinase domain hindered the ability of TRIB2 to induce leukaemia. An intact kinase domain was also necessary for TRIB2-induced leukaemia, and for Drosophila tribbles turnover of Slbo [26] . Generation of a TRIB2-KDM mutant which involved mutation of the LRDLKLRK sequence to resemble that of a typical active kinase HRDLKPEN abrogated the ability of TRIB2 to degrade C/EBPα and to prevent granulocytic differentiation. Mutation of the invariant Lys 177 (K177R) typical of an active serine/threonine kinase (one of the vestiges of an active kinase retained by tribbles proteins) to an arginine residue (typical of tyrosine kinase) interfered with TRIB2 function. K177R mediates only a partial degradation of C/EBPα and failed to induce leukaemia in the murine model [24] . Mutation of this conserved lysine residue in Drosophila K266R also impeded the ability of tribbles to degrade Slbo [26] . Taken together, the kinase domain is essential for the ability of tribbles to mediate degradation of C/EBPα.
Deletion of the COP1-binding site in TRIB2 or knockdown of COP1 expression resulted in an inability to degrade C/EBPα and failure to induce AML [24] . Therefore the degradation of C/EBPα via the E3 ligase COP1 was shown to be required for leukaemogenicity of TRIB2 [24] . TRIB2 has also been identified to degrade C/EBPα in another malignant context. In lung cancer cells, TRIB2 was identified to bind the E3 ligase TRIM21 by an unbiased immunoprecipitation-MS approach resulting in the degradation of C/EBPα [16] . The lung cancer cell line studied also expressed COP1, but no binding with TRIB2 was identified [16] . Overexpression of TRIB2 was identified in 30% of a subset of lung cancers, and 10-20% of these patients harbour a gene amplification due to amplification of 2q24, the chromosomal location of TRIB2 [16] . It is suggested that the E3 ligase associated with TRIB2 may be context-and tissue-dependent.
As mentioned above, TRIB3 has the least sequence similarity with TRIB1 and TRIB2 and was unable to induce leukaemia and degradation of C/EBPα [27] . Physical association of tribbles proteins with COP1 was first reported in the context of lipid metabolism [10] . Loss of insulin signalling in adipocytes was shown to increase the expression levels of TRIB3 [28] . TRIB3 transgenic mice displayed a leaner phenotype, increased energy expenditure and resistance to diet-induced obesity. MS experiments identified TRIB3 associated with both ACC1 (acetyl-CoA carboxylase 1) and COP1 [10] . ACC1 is the rate-limiting enzyme in fatty acid synthesis. TRIB3 association with COP1 resulted in ubiquitination and degradation of ACC1 [10] . TRIB3 mutants unable to bind COP1 were unable to ubiquitinate ACC1 and mediate its degradation. All three tribbles proteins were able to degrade ACC1 [27] , suggesting that the tribbles family do have some conserved degradative relationships. Under hypoxic conditions, TRIB3 was also shown to mediate proteolysis of a target protein. In response to hypoxic stress, tumour cells up-regulate TRIB3, which results in binding of ATF4 (activating transcription factor 4) and proteasomemediated degradation of both proteins. This is hypothesized to stall the stress response and allow the tumour cell more time to adapt to its environment [8] . Therefore the ability of tribbles to bind multiple proteins perpetuates the hypothesis that they function as adaptor molecules or scaffold proteins facilitating the assembly of multiprotein complexes resulting in degradation of the target protein.
Tribbles modulators of signalling
Control of cell signalling pathways provides a cell with the ability to respond to its extracellular environment and to control proliferation, differentiation, cell survival and apoptosis. Loss of cell signalling control or aberrant signalling is one of the hallmarks of cancer. Tribbles proteins have been identified to bind MEK1, MKK4 (MAPK kinase 4) and MKK7 [29] . Through their interactions with MAPK, tribbles proteins act as adaptor molecules that result in the modulation of signalling cascades, and it is thought that this is cell-typedependent [29] .
TRIB2 is reported to induce expression of the proinflammatory cytokine IL-8 (interleukin 8) in monocytes, a response which ultimately triggers an innate inflammatory response. It is suggested that TRIB2 mediates a change to signalling cascades through binding of MKK7 and MEK1, resulting in decreased phosphorylation of downstream activators JNK (c-Jun N-terminal kinases) and ERKs. This modulation leads to increased IL-8 production in monocytes. Indeed, in the Trib1-knockout mouse model [30] , defects in monocyte/macrophage inflammatory signalling are evident [30, 31] and reveal the important role of TRIB1 and TRIB2 in the inflammatory response.
Growth factors mediate their differentiation-inducing effects through MAPK signalling and MAPK are essential for normal haemopoiesis [32] . Aberrant activation of ERK1/2 and its upstream activator MEK1 have been frequently identified in acute leukaemias [33] . TRIB1 was identified to bind MEK1 at the C-terminal junction of the pseudokinase domain [3] . TRIB1-induced murine AML had increased ERK phosphorylation (P-ERK). Loss of MEK1 binding through deletion of the C-terminal deletion of the MEK1-binding motif or mutation of an essential tryptophan residue W337A abrogated the ability of TRIB1 to degrade C/EBPα and to increase p-ERK. Treatment with an inhibitor of MEK signalling blocked degradation of C/EBPα; however, the loss of C/EBPα binding did not affect TRIB1's ability to bind MEK1. A gain-of-function mutation R107L in TRIB1 was identified in an acute megakaryocytic leukaemia which further increased levels of p-ERK compared with wild-type (and increased degradation of C/EBPα), and this mutant induced leukaemia with a shorter latency than wild-type TRIB1 in a murine model [21] . Activation of the MEK1/ERK pathway phosphorylates C/EBPα and results in a block in granulopoiesis [34] ; however, TRIB1 overexpression was not found to have an effect on C/EBPα phosphorylation despite an increase in p-ERK [3] . Thus TRIB1 appears to utilize both the MEK/ERK pathway and C/EBPα degradation in AML induction, whereas in TRIB2-induced AML, no MEK/ERK involvement has been identified to date [27] .
Although not involved in leukaemia, TRIB3 modulation of the MAPK/ERK pathway has been shown to be important for breast cancer [35] . TRIB3 is also hypothesized to contribute to insulin resistance through inhibition of Akt phosphorylation [28] . TRIB3 was identified to bind Akt and to inhibit phosphorylation at Ser 473 and Thr 308 in hepatocytes with no change to total levels of Akt protein [28] . TRIB3 was shown to preferentially bind unphosphorylated Akt, and it is hypothesized that TRIB3 may shield Akt from phosphorylation [28] .
Another signalling function for TRIB2 has been implicated in the immune response through mediation of TLR (Tolllike receptor) signalling. TRIB2 was shown to negatively regulate TLR5-mediated activation of NF-κB (nuclear factor κB). This inhibition was attributed to TRIB2 binding directly to NF-κB2 (p100), mediating a phosphorylation change resulting in NF-κB2 decreasing activity of NF-κB [36] . Indeed, TRIB2 knockdown results in a decrease in TLRmediated phosphorylation of JNK and p38, but not ERK, and knockdown of TRIB2 in macrophages resulted in increased levels of p65 and IKK (inhibitor of NF-κB kinase) α and β phosphorylation [36] . TRIB2 is also induced by TLR5 and this feedback loop contributes to TRIB2-mediated control of the immune response.
Tribbles function as a decoy kinase
Tribbles may also function as decoy kinases, impinging on kinase activity by interfering with protein binding. An example of the potential decoy kinase function of tribbles is the interaction of TRIB3 and CHOP. During ER (endoplasmic reticulum) stress, CHOP (a member of the C/EBP family of bZIP transcription factors) is induced which leads to the up-regulation of TRIB3 expression [37] . TRIB3 was identified to bind CHOP at amino acids 10-18, resulting in the inhibition of CHOP's transcriptional activity [37, 38] . TRIB3 binding to CHOP excluded p300, a transcriptional co-activator, from its CHOP-binding site, revealing the inhibitory role of TRIB3 [38] . It was also demonstrated that TRIB3 inhibited p300 activation of ATF4 [37, 38] . This is an interesting situation in that TRIB3 does not induce proteolysis of its targets or signalling changes, and instead the physical association results in exclusion of a transcriptional co-activator from a gene promoter. These data suggest that, in this context, TRIB3 is in fact functioning as a decoy molecule by inhibiting binding of an activator protein [38] .
Conclusions
Tribbles' function as adaptor molecules comes from their ability to bind E3 ligases and MAPK family members. TRIB2 and TRIB3 were both identified to inhibit adipogenesis [17] . However, TRIB2 was shown to bind C/EBPβ and mediate proteolysis of LAP (liver-enriched activator protein), the active isoform of C/EBPβ, whereas TRIB3 did not result in proteolysis of C/EBPβ [17] . This situation nicely depicts the diverse functions of the tribbles proteins, that, whereas both TRIB2 and TRIB3 are able to inhibit adipocyte differentiation, only TRIB2 was identified to bind C/EBPβ and mediate its degradation [17] . The roles of tribbles in mediating degradation, signalling changes or functioning as a decoy may be determined by the cell context or by the identity of the target protein. Tribbles retain an evolutionarily conserved degradative relationship with the C/EBP family of transcription factors in more than one cell type. However, the ability of tribbles to modulate MAPK signalling appears to vary among tribbles proteins. It is clear that tribbles proteins exert multiple functions in cell biology through the adaptability of their interactions, and perhaps adaptors/decoys/pseudokinases are all correct terms for tribbles.
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